The next big step with experienced personalities

Please login or
register
23.09.2019
Photo L-R: Otto Bitterli, Machielse, Sergei Yakneen and Alisher Tashpulatov.

For the next stages on their roadmap, the startups Helvetic Care, Polyneuron, SOPHiA GENETICS and Crypto Finance have welcomed new members on board and the management committee. The startups seek to leverage the appointees’ expertise in the designated industries to foster further development from a strategic and operational point of view.

Two startups Helveitic Care and Polyneueron have both welcomed new members to their board of directors while the other two, SOPHiA GENETICS and Crypto Finance AG expanded their management teams. The descriptions below provide further insights about the appointees.

Helvetic Care

The Zug based startup Helveitic Care operates the platform «Orahou» which provides customers and their relatives with concrete help to deal with care situations which occur abruptly or gradually during the 4th phase of life. The current excessive demands on all those involved, the resulting resignation and ignorance of alternatives can lead to incapacitation. To help bring this solution to the next level and foster more transparency, Helvetic care welcomes Otto Bitterli as an investor and member of the board in Helvetic. Bitterli brings vast experience in the health insurance field, having been the CEO and chairman of the board of directors at Sanitas Health Insurance.

Polyneuron

Based in Basel, Polyneuron is a pioneering the development of a new class of biodegradable glycopolymers for the treatment of autoimmune diseases of the nervous system where a pathological role of anti-carbohydrate autoantibodies is well established. The company’s candidate drugs are based on its Antibody-Catch™ is a platform technology.

Polyneuron has recently appointed Ben Machielse as Chairman of the Board of Directors. Machielse has more than 25 years of experience in the biotech industry and was most recently CEO of Vtesse, which was subsequently acquired by Sucampo Pharmaceuticals. He has been involved with the successful development of multiple drugs, including the first H1N1 vaccine available to the public in the United States. His proven track record in developing a diverse range of therapeutics, including complex drugs for orphan diseases, will prove invaluable as we head towards clinical development of our lead program PN-1007 in anti-MAG neuropathy

SOPHiA GENETICS

SOPHiA is building the future of diagnostics and healthcare in cancer and rare diseases. Their unique approach relies on pulling from multiple sources of data, starting with genomics, adding radiomics and others in the future, to build multi-dimensional models of disease. SOPHiA also leverages the power of global collaboration through its fast-growing network of 1,000+ partners.

To help accelerate the realization of Sophia’s vision and impact the lives of millions worldwide, the startup has expanded its executive team with the appointment of Gaëtan Fraikin and Sergei Yakneen to the position of Chief Marketing Officer and Chief Information Officer, respectively. Fraikin and Yakneen bring decades of highly specialized experience from key players in the health tech industry.

Crypto Finance AG

Following continued growth and recognition in Switzerland and Europe, the Zug based startup Crypto Finance Group, offering regulated, professional asset management, brokerage, and storage solutions in digital assets, is expanding into Asia to provide professional investors access to the digital assets now gaining momentum in traditional financial markets. The company’s Asian clients can hence benefit from secure, regulated financial services in digital assets that offer Swiss finance sector expertise, best practice, and precision. The new subsidiary will be led by the newly appointed Alisher Tashpulatov as the Head of Asia Pacific. Alisher has previously spearheaded key business developments with the Crypto Fund AG asset management business.

With this announcement, Crypto Finance is dedicating significant expertise to the Asia Pacific, a dynamic, vital region that plays a major role in both the traditional financial sector and the emerging digital asset markets. With operations established and growing for professional investors in digital asset management, 24/7 brokerage, and storage infrastructure solutions for over 60 different digital assets, their secure, regulated approach to blockchain and crypto-asset investing is a market-leading solution chosen by clients in the financial industry.

(RAN)

Photo L-R: Otto Bitterli, Machielse, Sergei Yakneen and
Alisher Tashpulatov.

0Comments

Company profiles on startup.ch

Polyneuron Pharmaceuticals AG

Sophia Genetics SA

rss